Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Adenocarcinoma of Lung 2Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Radiomics 1Pituitary Diseases 1Pancreatic Ductal Adenocarcinoma 1Neuroendocrine Tumors 1Lung Neoplasms 1Lung Diseases 1Liver Cirrhosis 1Hepatitis B 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Disease Progression 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Carcinoma, Lobular 1Carcinoma, Hepatocellular 1Carcinoma, Ductal, Breast 1Breast Neoplasms 1Bone Neoplasms 1

Interventions

Sorafenib 20lenvatinib 18Hepatectomy 17Blood Specimen Collection 12Immune Checkpoint Inhibitors 11atezolizumab 9Liver Transplantation 9Surgical Procedures, Operative 7Radiofrequency Ablation 7Observation 7Bevacizumab 7regorafenib 5gadolinium ethoxybenzyl DTPA 5sintilimab 4donafenib 4camrelizumab 4Radiotherapy 4Magnetic Resonance Spectroscopy 4tislelizumab 3spartalizumab 3Polymerase Chain Reaction 3Neoadjuvant Therapy 3Mass Spectrometry 3Immunohistochemistry 3Doxorubicin 3Angiogenesis Inhibitors 3toripalimab 2pembrolizumab 2entecavir 2apatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Carcinoma, Hepatocellular × Radiomics × Clear all
NCT03221049 2021-09-02

Radiomics for Diagnosing Liver Diseases and Evaluating Progression

Third Affiliated Hospital, Sun Yat-Sen University

Unknown
3,000 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Liver Cirrhosis, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡